Drugs / oncolytic virus
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07145047 | Nov 2023 → Dec 2025 overdue | glioblastoma | Mianyang Central Hospital | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | oncolytic virus | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07145047 ↗ |
| Modality | Other / unclassified | “oncolytic viral agent” NCT07145047 ↗ |
| Route | Other | “Intratumoral injection of oncolytic virus.” NCT07145047 ↗ |